Zobrazeno 1 - 10
of 1 152
pro vyhledávání: '"Grubbs G"'
Autor:
Davey RT Jr; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: rdavey@niaid.nih.gov., Collins GL; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Rouphael N; Hope Clinic of Emory Vaccine Center, Emory University, Atlanta, GA, USA., Poliquin G; Public Health Agency of Canada, Children's Hospital Research Institute, Winnipeg, MB, Canada., McConnell R; Critical Care Medicine Department, Clinical Research Center, National Institutes of Health, Bethesda, MD, USA., Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research, US Food & Drug Administration, Silver Spring, MD, USA., Moir SL; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Langley JM; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada., Teitelbaum M; Clinical Monitoring Research Program, Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Hewlett AL; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA., McLellan SLF; Division of Infectious Diseases, Dept of Medicine, School of Medicine, University of Texas Medical Branch, Galveston, TX, USA., Bhadelia N; Boston University Center for Emerging Infectious Diseases Policy and Research, Boston University, Boston, MA, USA., Raabe VN; New York University Grossman School of Medicine, New York, NY, USA., Mulligan MJ; New York University Grossman School of Medicine, New York, NY, USA., Maljkovic Berry I; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Dighero-Kemp B; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Kurtz JR; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Hensley LE; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Dozier NCE; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Marron LCB; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., DuChene A; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Kuhn JH; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Brown SK; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research, US Food & Drug Administration, Silver Spring, MD, USA., Lane HC; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Neaton JD; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA.
Publikováno v:
The Lancet. Microbe [Lancet Microbe] 2024 Nov; Vol. 5 (11), pp. 100923. Date of Electronic Publication: 2024 Oct 04.
Autor:
Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA. Surender.Khurana@fda.hhs.gov., Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Ravichandran S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Cluff E; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Kim J; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Kuehne AI; Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, USA., Zak S; Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, USA., Dye JM; Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, USA., Lutwama JJ; Department of Arbovirology, Emerging, and Re-emerging Infection, Uganda Virus Research Institute, Entebbe, Uganda., Herbert AS; Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, USA.
Publikováno v:
Nature communications [Nat Commun] 2024 Sep 17; Vol. 15 (1), pp. 8133. Date of Electronic Publication: 2024 Sep 17.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bellusci L; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD 20871, USA., Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD 20871, USA., Sait S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD 20871, USA., Herbst KW; Division of Pediatric Infectious Diseases, Connecticut Children's, Hartford, CT 06106, USA., Salazar JC; Division of Pediatric Infectious Diseases, Connecticut Children's, Hartford, CT 06106, USA.; Departments of Pediatrics and Immunology, School of Medicine, University of Connecticut, Farmington, CT 06030, USA., Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD 20871, USA., The Connecticut Children's Covid Collaborative
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Jun 07; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 07.
Autor:
Lee Y; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Klenow L; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Coyle EM; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Golding H; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA. Surender.Khurana@fda.hhs.gov.
Publikováno v:
Nature communications [Nat Commun] 2024 Apr 04; Vol. 15 (1), pp. 2900. Date of Electronic Publication: 2024 Apr 04.
Autor:
Bellusci L; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Sait S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA., Yonker LM; Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, 02114, USA., Randolph AG; Department of Anesthesia, Harvard Medical School, Boston, MA, USA.; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, USA., Novak T; Department of Anesthesia, Harvard Medical School, Boston, MA, USA.; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, USA., Kobayashi T; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, USA., Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20993, USA. Surender.Khurana@fda.hhs.gov.
Publikováno v:
Nature communications [Nat Commun] 2023 Dec 01; Vol. 14 (1), pp. 7952. Date of Electronic Publication: 2023 Dec 01.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Parsons LM; Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Bacterial, Parasitic and Allergenic Products, Silver Spring, MD, United States., Zoueva O; Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Viral Products, Silver Spring, MD, United States., Grubbs G; Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Viral Products, Silver Spring, MD, United States., Plant E; Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Viral Products, Silver Spring, MD, United States., Jankowska E; Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Bacterial, Parasitic and Allergenic Products, Silver Spring, MD, United States., Xie Y; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China., Song H; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China., Gao GF; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China., Ye Z; Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Viral Products, Silver Spring, MD, United States., Khurana S; Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Viral Products, Silver Spring, MD, United States., Cipollo JF; Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Bacterial, Parasitic and Allergenic Products, Silver Spring, MD, United States.
Publikováno v:
Frontiers in molecular biosciences [Front Mol Biosci] 2023 Jun 13; Vol. 10, pp. 1207670. Date of Electronic Publication: 2023 Jun 13 (Print Publication: 2023).
Autor:
Grubbs, G. David
Publikováno v:
Science News, 2008 Apr 01. 173(15), 239-239.
Externí odkaz:
https://www.jstor.org/stable/20465415
Autor:
Stauft Cb, Golding B, Hana Golding, Huang C, Ravichandran S, Grubbs G, Surender Khurana, Tony T. Wang, Tang J, Lee Y
Publikováno v:
SSRN Electronic Journal.
Hyperimmune immunoglobulin (hCoV-2IG) preparations generated from SARS-CoV-2 convalescent plasma (CP) are under evaluation in several clinical trials of hospitalized COVID-19 patients. Here we explored the antibody epitope repertoire, antibody bindin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::863b7fcf729556547a2b47a791de2ce5
https://doi.org/10.2139/ssrn.3858916
https://doi.org/10.2139/ssrn.3858916